Last updated: 23 August 2024 at 4:15pm EST

Dr. William L. Macias M.D., Ph.D. Net Worth




The estimated Net Worth of William L. Macias is at least $12.7 Million dollars as of 21 August 2024. Dr Macias owns over 3,027 units of Immunovant Inc stock worth over $10,700,045 and over the last 3 years he sold IMVT stock worth over $2,007,263.

Dr D IMVT stock SEC Form 4 insiders trading

Dr has made over 17 trades of the Immunovant Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 3,027 units of IMVT stock worth $96,440 on 21 August 2024.

The largest trade he's ever made was selling 44,568 units of Immunovant Inc stock on 11 January 2023 worth over $746,514. On average, Dr trades about 4,838 units every 42 days since 2021. As of 21 August 2024 he still owns at least 368,332 units of Immunovant Inc stock.

You can see the complete history of Dr Macias stock trades at the bottom of the page.





Dr. William L. Macias M.D., Ph.D. biography

Dr. William L. Macias M.D., Ph.D. is the Chief Medical Officer at Immunovant Inc.



How old is Dr D?

Dr D is 63, he's been the Chief Medical Officer of Immunovant Inc since . There are 1 older and 13 younger executives at Immunovant Inc. The oldest executive at Immunovant Inc is Atul Pande, 65, who is the Independent Director.

What's Dr D's mailing address?

William's mailing address filed with the SEC is C/O IMMUNOVANT, INC., 320 W 37TH STREET, 6TH FLOOR, NEW YORK, NY, 10018.

Insiders trading at Immunovant Inc

Over the last 5 years, insiders at Immunovant Inc have traded over $21,959,710 worth of Immunovant Inc stock and bought 3,433,213 units worth $88,718,319 . The most active insiders traders include Sciences Ltd. Roivant, Peter Salzmann und Julia G. Butchko. On average, Immunovant Inc executives and independent directors trade stock every 14 days with the average trade being worth of $1,150,148. The most recent stock trade was executed by Mark S. Levine on 21 August 2024, trading 3,295 units of IMVT stock currently worth $104,979.



What does Immunovant Inc do?

immunovant, inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. it develops imvt-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in phase iia clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of phase ii clinical trials for the treatment of warm autoimmune hemolytic anemia. the company is headquartered in new york, new york. immunovant, inc. is a subsidiary of roivant sciences ltd.



What does Immunovant Inc's logo look like?

Immunovant Inc logo

Complete history of Dr Macias stock trades at Immunovant Inc

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
21 Aug 2024 William L. Macias
Chief Medical Officer
Verkauf 3,027 $31.86 $96,440
21 Aug 2024
368,332
17 Jul 2024 William L. Macias
Chief Medical Officer
Verkauf 3,044 $29.69 $90,376
17 Jul 2024
371,359
22 May 2024 William L. Macias
Chief Medical Officer
Verkauf 3,247 $29.65 $96,274
22 May 2024
374,403
17 Apr 2024 William L. Macias
Chief Medical Officer
Verkauf 8,280 $29.06 $240,617
17 Apr 2024
377,650
22 Feb 2024 William L. Macias
Chief Medical Officer
Verkauf 2,221 $36.15 $80,289
22 Feb 2024
330,952
18 Jan 2024 William L. Macias
Chief Medical Officer
Verkauf 424 $41.03 $17,397
18 Jan 2024
333,173
22 Nov 2023 William L. Macias
Chief Medical Officer
Verkauf 3,265 $32.78 $107,027
22 Nov 2023
333,597
19 Oct 2023 William L. Macias
Chief Medical Officer
Verkauf 530 $36.80 $19,504
19 Oct 2023
336,862
24 Aug 2023 William L. Macias
Chief Medical Officer
Verkauf 12,333 $20.30 $250,360
24 Aug 2023
337,392
19 Jul 2023 William L. Macias
Chief Medical Officer
Verkauf 426 $24.94 $10,624
19 Jul 2023
349,725
25 Apr 2023 William L. Macias
Chief Medical Officer
Verkauf 509 $16.29 $8,292
25 Apr 2023
350,151
2 Feb 2023 William L. Macias
Chief Medical Officer
Verkauf 537 $18.24 $9,795
2 Feb 2023
262,996
11 Jan 2023 William L. Macias
Chief Medical Officer
Verkauf 44,568 $16.75 $746,514
11 Jan 2023
263,533
21 Oct 2022 William L. Macias
Chief Medical Officer
Verkauf 341 $9.67 $3,297
21 Oct 2022
308,101
22 Jul 2022 William L. Macias
Chief Medical Officer
Verkauf 322 $4.70 $1,513
22 Jul 2022
195,626
19 Apr 2022 William L. Macias
Chief Medical Officer
Verkauf 1,392 $4.98 $6,932
19 Apr 2022
195,948
5 Jan 2022 William L. Macias
Chief Medical Officer
Verkauf 26,813 $8.28 $222,012
5 Jan 2022
197,340


Immunovant Inc executives and stock owners

Immunovant Inc executives and other stock owners filed with the SEC include: